Neogen Corporation’s Haloperidol Metabolites ELISA (Enzyme-Linked ImmunoSorbent Assay) test kit is a qualitative one-step kit designed for use as a screening device for the detection of Haloperidol metabolites. The kit was designed for screening purposes and is intended for forensic use only.
Intended Use
For the determination of trace quantities of Haloperidol Metabolites and/or other metabolites in human urine, blood or oral fluid. Contact a Neogen representative for information on other matrices.
Sensitivity
| Compound | I-50 in EIA Buffer |
| Haloperidol Metabolite (II) | 0.16 ng/mL |
| Haloperidol | 0.19 ng/mL |
| Haloperidol Metabolite (I) | 0.33 ng/mL |
| Bromperidol | 0.21 ng/mL |
Specificity (Cross-Reactivity)
| Compound | Cross-Reactivity |
| Bromperidol | 157% |
| Haloperidol Metabolite (II) [+(-)-4-(4-chlorophenyl)-a(4-fluorophenyl)-4-hydroxy-1piperidinebutanol] |
100% |
| Haloperidol | 84% |
| Haloperidol Metabolite (I) [4-(4-chlorophenyl)-4-hydroxypiperidine] |
48% |
| Azaperone | 0.002% |
Order Details
| Product # | Product Description |
| 102119 | Haloperidol Metabolites, 96 well kit |
| 102116 | Haloperidol Metabolites, 480 well kit |
For forensic use only.